Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice

Bryan Holvoet, Mattia Quattrocelli, Sarah Belderbos, Lore Pollaris, Esther Wolfs, Olivier Gheysens, Rik Gijsbers, Jeroen Vanoirbeek, Catherine M. Verfaillie, Maurilio Sampaolesi, Christophe M. Deroose*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Muscular dystrophies are a heterogeneous group of myopathies, characterized by muscle weakness and degeneration, without curative treatment. Mesoangioblasts (MABs) have been proposed as a potential regenerative therapy. To improve our understanding of the in vivo behavior of MABs and the effect of different immunosuppressive therapies, like cyclosporine A or co-stimulation-adhesion blockade therapy, on cell survival noninvasive cell monitoring is required. Therefore, cells were transduced with a lentiviral vector encoding firefly luciferase (Fluc) and the human sodium iodide transporter (hNIS) to allow cell monitoring via bioluminescence imaging (BLI) and small-animal positron emission tomography (PET). Non-H2 matched mMABs were injected in the femoral artery of dystrophic mice and were clearly visible via small-animal PET and BLI. Based on noninvasive imaging data, we were able to show that co-stim was clearly superior to CsA in reducing cell rejection and this was mediated via a reduction in cytotoxic T cells and upregulation of regulatory T cells.

Original languageEnglish (US)
Pages (from-to)1183-1195
Number of pages13
JournalStem cell reports
Issue number6
StatePublished - Dec 8 2015

ASJC Scopus subject areas

  • Genetics
  • Biochemistry
  • Cell Biology
  • Developmental Biology


Dive into the research topics of 'Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice'. Together they form a unique fingerprint.

Cite this